Summary
The company lifted its revenue outlook for the year, saying it expects revenue to grow as much as 25% in 2026.
Moderna’s stock jumps after biotech raises sales outlook
Source & full coverage: this summary is aggregated from MarketWatch, the original publisher. Read the complete report for full context, data and quotes.
Read the original report at MarketWatch →
